2 research outputs found

    Additional file 2: Table S1. of The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)

    No full text
    The breakdown of where individuals receive treatment. Table S2. Regional specific patient medical expenses and health system costs. Table S3. DALYs averted stratified by WHO region. Table S4. Economic benefits for individuals and the health systems stratified by the WHO regions. Table S5. Impact of the sensitivity analysis on the projected health benefits of the GPELF (2000–2014). Table S6. Impact of the sensitivity analysis on the projected economic benefits of the GPELF (2000–2014). (DOCX 28 kb
    corecore